Influence of step length on 6-minute walk test performance in patients with chronic heart failure

Garyfallia K Pepera1, Gavin R Sandercock, Rebecca Sloan

  • 1Department of Biological Sciences, University of Essex, Colchester, UK. hilary.gunn100@plymouth.ac.uk

Physiotherapy
|November 6, 2012
PubMed

Insights

Patients with chronic heart failure (CHF) exhibit reduced step length and walking speed during the 6-minute walking test (6MWT). These altered gait mechanics may limit exercise capacity in individuals with CHF.

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Gait Analysis

Background:

  • Chronic heart failure (CHF) significantly impacts patients' functional capacity.
  • The 6-minute walking test (6MWT) is a standard measure of exercise tolerance in CHF.
  • Gait parameters like step length and walking speed are crucial determinants of walking performance.

Purpose of the Study:

  • To examine the influence of gait parameters, specifically step length and walking speed, during the 6MWT in patients with CHF.
  • To compare gait parameters between patients with CHF and healthy controls during the 6MWT.

Main Methods:

  • An observational study conducted in a specialist heart failure clinic.
  • Participants included patients with CHF and age-matched healthy controls.
  • Gait parameters (step length, walking speed) were measured minute-by-minute during a standardized 6MWT protocol.

Main Results:

  • Patients with CHF demonstrated significantly shorter step length and slower walking speed compared to healthy controls within the first five minutes of the 6MWT.
  • No significant minute-by-minute changes in step length or walking speed were observed in the CHF group during the test.
  • Body mass index was identified as a key predictor of 6MWT performance in patients with CHF.

Conclusions:

  • Patients with CHF exhibit impaired gait mechanics, characterized by reduced step length and walking speed, during the 6MWT.
  • These altered gait characteristics are likely contributors to the limited exercise capacity observed in individuals with CHF.
  • Further research into gait interventions may be beneficial for improving functional outcomes in CHF patients.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...